
Altria (MO) Stock Forecast & Price Target
Altria (MO) Analyst Ratings
Bulls say
Altria Group continues to maintain its dominance in the U.S. tobacco market, with the Marlboro brand accounting for a remarkable 42% market share in 2024 alongside an 8.8% retail share in the oral tobacco segment, reflecting consistent growth. The company's investment in its oral products, particularly the On! brand, is expected to enhance its profit margins while supporting topline outperformance. Furthermore, the recent PMTA approval for On! Plus is anticipated to drive further growth in the oral segment, contributing to an improved revenue mix and profitability in the coming years.
Bears say
Altria Group's stock faces a negative outlook primarily due to a deteriorating macroeconomic environment, leading to reduced demand elasticity and pressure on segment margins. The declining cigarette incidence rate, with less than 15% of consumers aged 18 and above indicating recent cigarette usage, exacerbates concerns about the sustainability of Altria's core revenue streams. Furthermore, the performance of its smokeless tobacco segment is hindered by challenges in legacy brands, overshadowing any growth from newer products like On!, which is also experiencing a slowdown.
This aggregate rating is based on analysts' research of Altria and is not a guaranteed prediction by Public.com or investment advice.
Altria (MO) Analyst Forecast & Price Prediction
Start investing in Altria (MO)
Order type
Buy in
Order amount
Est. shares
0 shares